Manufacturer: Janssen-Cilag manufactures Vermox.


The uses of Vermox include:

VERMOX tablets and suspension are indicated for the treatment of single or mixed helminthic infestations. Clinical studies have shown mebendazole to be effective in the treatment of Enterobius vermicularis (threadworm), Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm) and of Ancylostoma duodenale and Necator americanus (hookworm).

Efficacy varies as a function of such factors as pre-existing diarrhoea, gastrointestinal transit time, degree of infection, and helminth strain.

Dosage and Administration

VERMOX is administered orally.

For control of enterobiasis:

One tablet (100 mg) or 5 mL spoonful of suspension (100 mg) is given. Since reinfections by Enterobius are known to be very frequent, it is recommended that treatment be repeated after 2 to 4 weeks, especially in eradication programmes.

For control of trichuriasis, ascariasis, ancylostomiasis, and mixed infections:

One VERMOX tablet (100 mg) or 5 mL spoonful of suspension (100 mg) is administered in the morning and evening for three consecutive days.


The same dosage may be given to children (1 to 12 years) as to adults. As safety and efficacy has not been established in children under 1 year its use is not recommended for this age group.

If the patient is not cured three weeks after treatment, a second course of treatment is advised.

No special procedures such as fasting or the use of laxative are required.